Research•July 20, 2026•By Dr. Elena
Understanding Tirzepatide: Dual GIP/GLP-1 Mechanism
Understanding Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist developed for the treatment of type 2 diabetes and obesity. Its unique mechanism of action involves:
- GIP receptor activation: Enhances insulin secretion in a glucose-dependent manner.
- GLP-1 receptor activation: Suppresses glucagon secretion and slows gastric emptying.
Clinical Implications
Recent studies have shown that Tirzepatide achieves superior glycemic control compared to selective GLP-1 receptor agonists. This is attributed to the synergistic effect of GIP and GLP-1 co-agonism.
Research Applications
At Veritas Bio Labs, we supply high-purity (>99%) lyophilized Tirzepatide for research purposes. Our product is available in dosages ranging from 5 mg to 120 mg, catering to diverse experimental designs.
#Tirzepatide#GLP-1#Metabolic